Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne-Reference-Cited by-同舟云学术

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

Published:2017-12 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lourbakos A.,Yau N.,de Bruijn P.,Hiller M.,Kozaczynska K.,Jean-Baptiste R.,Reza M.,Wolterbeek R.,Koeks Z.,Ayoglu B.,de Klerk D.,Campion G.,Zaharieva I.,Nadarajah V. D.,Nilsson P.,Al-Khalili Szigyarto C.,Muntoni F.,Lochmüller H.,Verschuuren J. J.^ORCID,Goemans N.,Tulinius M.,Niks E. H.,de Kimpe S.,Aartsma-Rus A.,’t Hoen Peter A. C.^ORCID,Spitali P.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-17982-y.pdf

Reference42 articles.

1. Ellis, J. A., Vroom, E. & Muntoni, F. 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14–16th December, 2012, Naarden, The Netherlands. Neuromuscul. Disord. 23, 682–689 (2013).

2. Helderman-van den Enden, A. T. J. M. et al. An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy. Eur. J. Hum. Genet. 1–6 https://doi.org/10.1038/ejhg.2012.101 (2012).

3. van den Bergen, J. C. et al. Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy. J. Neurol. Neurosurg. Psychiatry 85, 92–8 (2014).

4. Henricson, E. K. et al. Thecooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and othe. Muscle Nerve 48, 55–67 (2013).

5. Aartsma-Rus, A. Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum. Mol. Genet. 12, 907–914 (2003).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-terminal titin fragment: a non-invasive, pharmacodynamic biomarker for microdystrophin efficacy;Skeletal Muscle;2024-01-16

2. Neuromuscular disorders in the omics era;Clinica Chimica Acta;2024-01

3. Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions;Journal of Neuromuscular Diseases;2023-11-07

4. Levels of Matrix Metalloproteinase 9 Are Elevated in Persons With Schizophrenia or Bipolar Disorder: The Role of Modifiable Factors;Biological Psychiatry Global Open Science;2023-10

5. Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology;Heliyon;2023-08